Novo Nordisk
NVO
#86
Rank
โ‚ฌ174.37 B
Marketcap
39,34ย โ‚ฌ
Share price
-2.72%
Change (1 day)
-31.64%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2026 (TTM): โ‚ฌ21.40 Billion

According to Novo Nordisk's latest financial reports the company's current earnings are โ‚ฌ51.37 Billion. In 2025 the company made an earning of โ‚ฌ18.00 Billion, an increase over its 2024 earnings that were of โ‚ฌ16.93 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚ฌ21.40 B18.9%
2025 โ‚ฌ18.00 B6.28%
2024 โ‚ฌ16.93 B28.01%
2023 โ‚ฌ13.23 B57.81%
2022 โ‚ฌ8.38 B5.24%
2021 โ‚ฌ7.96 B12.38%
2020 โ‚ฌ7.09 B13.11%
2019 โ‚ฌ6.26 B-3.45%
2018 โ‚ฌ6.49 B1.88%
2017 โ‚ฌ6.37 B4.3%
2016 โ‚ฌ6.10 B10.32%
2015 โ‚ฌ5.53 B7.47%
2014 โ‚ฌ5.15 B3.4%
2013 โ‚ฌ4.98 B19.09%
2012 โ‚ฌ4.18 B15.58%
2011 โ‚ฌ3.62 B16.58%
2010 โ‚ฌ3.10 B25.66%
2009 โ‚ฌ2.47 B10.68%
2008 โ‚ฌ2.23 B55.82%
2007 โ‚ฌ1.43 B7.02%
2006 โ‚ฌ1.33 B19.05%
2005 โ‚ฌ1.12 B10.55%
2004 โ‚ฌ1.01 B
2002 โ‚ฌ0.70 B-14.39%
2001 โ‚ฌ0.82 B-52.82%
2000 โ‚ฌ1.75 B250%
1999 โ‚ฌ0.50 B31.21%
1998 โ‚ฌ0.38 B34.31%
1997 โ‚ฌ0.28 B11.46%
1996 โ‚ฌ0.25 B9.03%
1995 โ‚ฌ0.23 B-3.15%
1994 โ‚ฌ0.24 B-0.67%
1993 โ‚ฌ0.24 B45.38%
1992 โ‚ฌ0.16 B-13.81%
1991 โ‚ฌ0.19 B37.12%
1990 โ‚ฌ0.14 B-0.79%
1989 โ‚ฌ0.14 B26.2%
1988 โ‚ฌ0.11 B24.97%
1987 โ‚ฌ90.47 M-0.9%
1986 โ‚ฌ91.3 M-7.78%
1985 โ‚ฌ99.01 M24.87%
1984 โ‚ฌ79.28 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚ฌ9.09 B-57.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ26.73 B 24.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ6.57 B-69.38%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
โ‚ฌ8.24 B-61.63%๐Ÿ‡บ๐Ÿ‡ธ USA